http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2667418-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4f16e71d2cc81c549e81470d725e224
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-52
filingDate 2012-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f0803dfcea58d1d2c444e36db724771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96913965c08b6cb3dbf700c67760a5c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8bb4da4dfb0bf39d2460cab67ea13fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6307ec4ace1ef67c84bc86ec9db5da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e66fbb8a90d87688cfa6ee103e6187ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb12c01b096b02905bbe287f7365eeda
publicationDate 2018-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2667418-T3
titleOfInvention Compositions and methods for the treatment of celiac disease
abstract A polypeptide comprising an amino acid sequence at least 75% identical to an amino acid sequence according to SEQ ID NO: 35, wherein (a) the polypeptide degrades a PQPQLP peptide (SEQ ID NO: 34) at pH 4 ; (b) the remainder 278 is Ser, the remainder 78 is Glu and the remainder 82 is Asp; and (c) the polypeptide comprises an amino acid change of SEQ ID NO: 67 in one or more moieties selected from the group consisting of 73, 102, 103, 104, 130, 165, 168, 169, 172 and 179, in wherein said one or more amino acid changes of SEQ ID NO: 67 include at least G130S, D169G and D179H, or said one or more amino acid changes of SEQ ID NO: 67 include at least N102D.
priorityDate 2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID192387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411319801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445691
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID192387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586568

Total number of triples: 32.